BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18487244)

  • 1. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.
    Ashley N; O'Rourke A; Smith C; Adams S; Gowda V; Zeviani M; Brown GK; Fratter C; Poulton J
    Hum Mol Genet; 2008 Aug; 17(16):2496-506. PubMed ID: 18487244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.
    Horvath R; Hudson G; Ferrari G; Fütterer N; Ahola S; Lamantea E; Prokisch H; Lochmüller H; McFarland R; Ramesh V; Klopstock T; Freisinger P; Salvi F; Mayr JA; Santer R; Tesarova M; Zeman J; Udd B; Taylor RW; Turnbull D; Hanna M; Fialho D; Suomalainen A; Zeviani M; Chinnery PF
    Brain; 2006 Jul; 129(Pt 7):1674-84. PubMed ID: 16621917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.
    Taanman JW; Rahman S; Pagnamenta AT; Morris AA; Bitner-Glindzicz M; Wolf NI; Leonard JV; Clayton PT; Schapira AH
    Hum Mutat; 2009 Feb; 30(2):248-54. PubMed ID: 18828154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression.
    Qian Y; Kachroo AH; Yellman CM; Marcotte EM; Johnson KA
    J Biol Chem; 2014 Feb; 289(9):5970-85. PubMed ID: 24398692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POLG1 mutations associated with progressive encephalopathy in childhood.
    Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
    Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
    Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA.
    Ferrari G; Lamantea E; Donati A; Filosto M; Briem E; Carrara F; Parini R; Simonati A; Santer R; Zeviani M
    Brain; 2005 Apr; 128(Pt 4):723-31. PubMed ID: 15689359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note.
    de Vries MC; Rodenburg RJ; Morava E; Lammens M; van den Heuvel LP; Korenke GC; Smeitink JA
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S299-302. PubMed ID: 18500570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome.
    Schaller A; Hahn D; Jackson CB; Kern I; Chardot C; Belli DC; Gallati S; Nuoffer JM
    BMC Neurol; 2011 Jan; 11():4. PubMed ID: 21235791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic variability in Alpers syndrome.
    Sofou K; Moslemi AR; Kollberg G; Bjarnadóttir I; Oldfors A; Nennesmo I; Holme E; Tulinius M; Darin N
    Eur J Paediatr Neurol; 2012 Jul; 16(4):379-89. PubMed ID: 22237560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts.
    Stewart JD; Schoeler S; Sitarz KS; Horvath R; Hallmann K; Pyle A; Yu-Wai-Man P; Taylor RW; Samuels DC; Kunz WS; Chinnery PF
    Biochim Biophys Acta; 2011 Mar; 1812(3):321-5. PubMed ID: 21138766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome.
    Naviaux RK; Nyhan WL; Barshop BA; Poulton J; Markusic D; Karpinski NC; Haas RH
    Ann Neurol; 1999 Jan; 45(1):54-8. PubMed ID: 9894877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POLG mutations and Alpers syndrome.
    Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
    Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.
    Tang S; Dimberg EL; Milone M; Wong LJ
    J Neurol; 2012 May; 259(5):862-8. PubMed ID: 21993618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children.
    Stewart JD; Tennant S; Powell H; Pyle A; Blakely EL; He L; Hudson G; Roberts M; du Plessis D; Gow D; Mewasingh LD; Hanna MG; Omer S; Morris AA; Roxburgh R; Livingston JH; McFarland R; Turnbull DM; Chinnery PF; Taylor RW
    J Med Genet; 2009 Mar; 46(3):209-14. PubMed ID: 19251978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.
    Chan SS; Longley MJ; Naviaux RK; Copeland WC
    DNA Repair (Amst); 2005 Dec; 4(12):1381-9. PubMed ID: 16181814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.
    de Vries MC; Rodenburg RJ; Morava E; van Kaauwen EP; ter Laak H; Mullaart RA; Snoeck IN; van Hasselt PM; Harding P; van den Heuvel LP; Smeitink JA
    Eur J Pediatr; 2007 Mar; 166(3):229-34. PubMed ID: 16957900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POLG1 manifestations in childhood.
    Isohanni P; Hakonen AH; Euro L; Paetau I; Linnankivi T; Liukkonen E; Wallden T; Luostarinen L; Valanne L; Paetau A; Uusimaa J; Lönnqvist T; Suomalainen A; Pihko H
    Neurology; 2011 Mar; 76(9):811-5. PubMed ID: 21357833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
    Naviaux RK; Nguyen KV
    Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol γ.
    Euro L; Farnum GA; Palin E; Suomalainen A; Kaguni LS
    Nucleic Acids Res; 2011 Nov; 39(21):9072-84. PubMed ID: 21824913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.